Improved detection rate of cytogenetic abnormalities in chronic lymphocytic leukemia and other mature B-cell neoplasms with use of CpG-oligonucleotide DSP30 and interleukin 2 stimulation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Clinical Pathology

• Publication date

  2013-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1309/AJCP7G4VMYZJQVFIPMID 23596118
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate.

  2011cited by this paper
• Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.

  2010cited by this paper
• Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors

  2010cited by this paper
• Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.

  2010cited by this paper
• Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin‐2 stimulation: A Belgian multicentric study

  2009cited by this paper
• Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping

  2007cited by this paper
• Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.

  2006cited by this paper
• Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.

  2006cited by this paper
• CpG stimulation of precursor B-lineage acute lymphoblastic leukemia induces a distinct change in costimulatory molecule expression and shifts allogeneic T cells toward a Th1 response.

  2005cited by this paper
• Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

  2001cited by this paper
• bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use

  2001cited by this paper
• Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells1

  2001cited by this paper
• CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens

  2001cited by this paper
• Genomic aberrations and survival in chronic lymphocytic leukemia.

  2000cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype.

  2000cited by this paper
• Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.

  2000cited by this paper
• Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications.

  1997cited by this paper
• Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients

  1996cited by this paper
• Chronic lymphocytic leukemia.

  1995cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.

  1990cited by this paper
• Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma.

  1985cited by this paper
• Prognostic information from cytogenetic analysis in chronic B- lymphocytic leukemia and leukemic immunocytoma

  1985cited by this paper

• Performance of CpG-oligonucleotide DSP30 and interleukin-2 in the cytogenetic study of mature B-cell neoplasms: a systematic review and meta-analysis.

  2025cites this paper
• Chinese expert consensus on hematologic malignancy karyotyping.

  2025cites this paper
• Section E6.1-6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone marrow, and lymph nodes.

  2024cites this paper
• Cancer cytogenetics in a genomics world: Wedding the old with the new.

  2024cites this paper
• Cell Culture and Slide Preparation for Cytogenetic Studies of Hematological Neoplasms.

  2024cites this paper
• DSP30和IL-2在慢性淋巴细胞白血病常规染色体检测中的应用

  2020cites this paper
• ЭФФЕКТИВНОСТЬ ИСПОЛЬЗОВАНИЯ ОЛИГОНУКЛЕОТИДА DSP30 В СОЧЕТАНИИ С ИНТЕРЛЕЙКИНОМ-2 ДЛЯ ВЫЯВЛЕНИЯ ХРОМОСОМНЫХ АБЕРРАЦИЙ У БОЛЬНЫХ ХРОНИЧЕСКИМ ЛИМФОЛЕЙКОЗОМ

  2019cites this paper
• Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.

  2018cites this paper
• DSP30 and interleukin‐2 as a mitotic stimulant in B‐cell disorders including those with a low disease burden

  2018cites this paper
• Prognostic Indicators in CLL: Clinical, Cytogenetics, Novel Mutations, MicroRNAs, Hierarchal Classification

  2018cites this paper
• Significance of Cytogenetics in Leukemia Diagnostics

  2018cites this paper
• Chromosome Preparation for Chronic Lymphoid Malignancies.

  2017cites this paper
• Comparison of Diagnostic Yield of a FISH Panel Against Conventional Cytogenetic Studies for Hematological Malignancies: A South Indian Referral Laboratory Analysis Of 201 Cases

  2017cites this paper
• CpG-ODN Stimulation in Population Screening Monoclonal B-Cell Lymphocytosis.

  2017cites this paper
• Section E6.1–6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow–acquired chromosomal abnormalities

  2016cites this paper
• Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia–Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears

  2016cites this paper
• FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG‐stimulated chronic lymphocytic leukemia

  2016cites this paper
• Efficacy of DSP30‐IL2/TPA for detection of cytogenetic abnormalities in chronic lymphocytic leukaemia/small lymphocytic lymphoma

  2016cites this paper
• Comprehensive Genetic Analysis by Integration of Conventional Karyotyping and Interphase FISH Helps Refinement of Biological Subclasses with Clinical Impact in Chronic Lymphocytic Leukemia

  2016cites this paper
• Detection of chromosomal changes in chronic lymphocytic leukemia using classical cytogenetic methods and FISH: application of rich mitogen mixtures for lymphocyte cultures

  2016cites this paper
• Detection of chromothripsis‐like patterns with a custom array platform for chronic lymphocytic leukemia

  2015cites this paper
• CpG Oligonucleotide and Interleukin 2 stimulation enables higher cytogenetic abnormality detection rates than 12-o-tetradecanolyphorbol-13-acetate in Asian patients with B-cell chronic lymphocytic leukemia (B-CLL)

  2014influential citation
• Contribution of MLPA to routine testing to detect the prognostic chromosomal abnormalities in chronic lymphocytic leukemia

  2014cites this paper
• Detection of Clonal Aberrations by Cytogenetic Analysis after Different Culture Methods and by FISH in 129 Patients with Chronic Lymphocytic Leukemia

  2014influential citation
• Translocation t(2;7)(p11;q21) associated with the CDK6/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies.

  2014cites this paper
• New Developments in Chronic Lymphocytic Leukaemia Diagnosis

  2013cites this paper